Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Jupiter Acquisition Corporation (Amendment)SC 13G/A - Jupiter Acquisition Corp (0001817868) (Subject)
- 13D/GSEC Form SC 13G/A filed by Jupiter Acquisition Corporation (Amendment)SC 13G/A - Jupiter Acquisition Corp (0001817868) (Subject)
- 13D/GSEC Form SC 13G/A filed by Jupiter Acquisition Corporation (Amendment)SC 13G/A - Jupiter Acquisition Corp (0001817868) (Subject)
- 13D/GSEC Form SC 13G/A filed by Jupiter Acquisition Corporation (Amendment)SC 13G/A - Jupiter Acquisition Corp (0001817868) (Subject)
- 13D/GSEC Form SC 13G/A filed by Jupiter Acquisition Corporation (Amendment)SC 13G/A - Jupiter Acquisition Corp (0001817868) (Subject)
- 13D/GSEC Form SC 13G/A filed by Jupiter Acquisition Corporation (Amendment)SC 13G/A - Jupiter Acquisition Corp (0001817868) (Subject)
- SECSEC Form 15-12G filed by Jupiter Acquisition Corporation15-12G - Jupiter Acquisition Corp (0001817868) (Filer)
- SECJupiter Acquisition Corporation filed SEC Form 8-K: Other Events8-K - Jupiter Acquisition Corp (0001817868) (Filer)
- SECSEC Form 25-NSE filed by Jupiter Acquisition Corporation25-NSE - Jupiter Acquisition Corp (0001817868) (Subject)
- SECJupiter Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - Jupiter Acquisition Corp (0001817868) (Filer)
- NEWSJupiter Acquisition Mutually Agrees To Terminate Filament Health Merger, Cancels Special Meeting Of Stockholders, And Redeems Public SharesJupiter Acquisition announced the mutually agreed termination of the previously announced business combination agreement with Filament Health Corp. (the "Business Combination Agreement"). The special meeting of stockholders of Jupiter scheduled to reconvene on Thursday, December 28, 2023, at 12:00 p.m. Eastern Time, at which stockholders of Jupiter were to be asked to vote to approve the Business Combination Agreement and the business combination contemplated thereby, among other related matters, has been cancelled. Jupiter will redeem all of the outstanding shares of its Class A common stock issued as part of the units sold in Jupiter's initial public offering (the "IPO", and such shares,
- PRFILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATIONVANCOUVER, BC, Dec. 19, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that the Business Combination Agreement, by and among the Company, Jupiter Acquisition Corporation (NASDAQ:JAQC) ("Jupiter"), 1427702 B.C. Ltd. ("TopCo") and Filament Merger Sub LLC, dated as of July 18, 2023 (as amended by the First Amendment to the Business Combination Agreement, the "Business Combination Agreement"), with respect to a proposed business combination between Filament and Jupiter (the "Proposed Business Combination"), has been terminated by the parties by mutual agreement.
- PRJupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Public SharesHobe Sound, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) ("Jupiter") today announced the mutually agreed termination of the previously announced business combination agreement with Filament Health Corp. (the "Business Combination Agreement"). The special meeting of stockholders of Jupiter scheduled to reconvene on Thursday, December 28, 2023, at 12:00 p.m. Eastern Time, at which stockholders of Jupiter were to be asked to vote to approve the Business Combination Agreement and the business combination contemplated thereby, among other related matters, has been cancelled. Jupiter will redeem all of the outstanding shares of its Class A common stock i
- PRFILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISEVANCOUVER, BC, Dec. 18, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that the special meeting of its securityholders held this Monday, December 18, 2023 at 9:30 a.m. (Vancouver time) (the "Special Meeting") to approve, among other things, the Company's proposed arrangement (the "Arrangement") under Part 9, Division 5 of the Business Corporations Act (British Columbia) was terminated. At the Special Meeting, the Arrangement Resolution attached to the management information circular of Filament dated November 7, 2023 (the "Circular") was not presented to the se
- SECSEC Form DEFA14A filed by Jupiter Acquisition CorporationDEFA14A - Jupiter Acquisition Corp (0001817868) (Filer)
- SECJupiter Acquisition Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Jupiter Acquisition Corp (0001817868) (Filer)
- SECSEC Form DEFA14A filed by Jupiter Acquisition CorporationDEFA14A - Jupiter Acquisition Corp (0001817868) (Filer)
- PRJupiter Acquisition Corporation Announces Intent to Reconvene and Adjourn its Special Meeting of Stockholders to December 18, 2023Hobe Sound, FL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) ("Jupiter") today announced that it intends to reconvene and then adjourn, without conducting any business, the special meeting of stockholders of Jupiter (the "Business Combination Special Meeting") scheduled to reconvene on Tuesday, December 12, 2023, at 12:00 p.m. Eastern Time, until Monday, December 18, 2023, at 12:00 p.m. Eastern Time, as a completely virtual meeting conducted via live webcast, which will be available at https://www.cstproxy.com/jupiteracquisitioncorp/sm2023. At the Business Combination Special Meeting, once further reconvened, stockholders of Jupiter will be asked to vote
- PRFILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETINGVANCOUVER, BC, Dec. 11, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, announces that the special meeting of its securityholders to be held this Monday, December 11, 2023 at 9:30 a.m. (Vancouver time) (the "Special Meeting") to approve, among other things, the Company's proposed arrangement (the "Arrangement") under Part 9, Division 5 of the Business Corporations Act (British Columbia) (the "Act") has been adjourned. The Special Meeting has been adjourned in acc
- SECSEC Form DEFA14A filed by Jupiter Acquisition CorporationDEFA14A - Jupiter Acquisition Corp (0001817868) (Filer)
- SECSEC Form DEFA14A filed by Jupiter Acquisition CorporationDEFA14A - Jupiter Acquisition Corp (0001817868) (Filer)
- SECSEC Form DEFA14A filed by Jupiter Acquisition CorporationDEFA14A - Jupiter Acquisition Corp (0001817868) (Filer)
- PRFILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS COMBINATIONVANCOUVER, BC, Dec. 6, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, is pleased to announce that, further to its press release dated November 23, 2023, the Company has entered into a definitive securities purchase agreement (the "Securities Purchase Agreement") with Helena Global Investment Opportunities 1 Ltd. (the "Note Investor"), an affiliate of Helena Partners Inc., a Cayman-Islands based advisor and investor ("Helena") and 1427702 B.C. Ltd. ("TopCo"), providing for up to USD$14.4 million in funding through the issuance of senior secured convertible notes (the "Notes" an
- SECSEC Form DEFA14A filed by Jupiter Acquisition CorporationDEFA14A - Jupiter Acquisition Corp (0001817868) (Filer)
- SECJupiter Acquisition Corporation filed SEC Form 8-K: Other Events8-K - Jupiter Acquisition Corp (0001817868) (Filer)
JAQC FAQ
6 questionsWhat does Jupiter Acquisition Corporation do?
Jupiter Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Hobe Sound, Florida.Where does JAQC stock trade?
Jupiter Acquisition Corporation (JAQC) is listed on NASDAQ.What sector and industry is JAQC in?
Jupiter Acquisition Corporation operates in the Finance sector, Blank Checks industry.When did Jupiter Acquisition Corporation go public?
Jupiter Acquisition Corporation (JAQC) completed its IPO in 2021.What companies are similar to JAQC?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare JAQC side-by-side with any of them on Quantisnow.How can I track JAQC on Quantisnow?
Quantisnow aggregates Jupiter Acquisition Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow JAQC to receive live email and push alerts on every new disclosure.